Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 22.6B | 23.3B | 21.6B | 21.6B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 11.0B | 11.4B | 10.5B | 10.3B |
Other operating expenses | — | — | — | — |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 6.6B | 6.9B | 6.1B | 6.2B |
Tax provision | 487.5M | 613.7M | 377.6M | 364.8M |
Net income | 6.1B | 6.3B | 5.7B | 5.9B |
Basic EPS | 0.9 | 0.9 | 0.8 | 0.8 |
Diluted EPS | 0.9 | 0.9 | 0.8 | 0.8 |
Basic average shares | 6.5B | 6.5B | 6.6B | 6.7B |
Diluted average shares | 6.5B | 6.6B | 6.7B | 6.7B |
EBITDA | — | — | — | — |
Net income from continuing op. | 6.1B | 6.3B | 5.7B | 5.9B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |